Stocks · Health care · Pharmaceutical Preparations

Organogenesis Holdings Inc.

ORGO Clue Score57
United States Fiscal year ends December CIK 0001661181 Results filed 5 Nov 2026

What the insiders did Net selling

Insider
Date
Role
Action
Shares
Price
Amount
Brian Grow
11 Aug 2025
Chief Commercial Officer
Exercised, kept
4,060
$2.47
$10.03K
Brian Grow
10 Jan 2025
Chief Commercial Officer
Exercised, kept
958
$1.24
$1.19K
Gary S. Gillheeney
5 Dec 2024
President and CEO
Exercised, kept
1,067,245
$0.99
$1.06M
Patrick Bilbo
28 Mar 2024
Chief Operating Officer
Exercised, kept
152,250
$1.18
$179.66K
Brian Grow
20 Aug 2022
Chief Commercial Officer
Exercised, kept
805
$1.46
$1.18K
Gary S. Gillheeney
30 Jun 2022
President and CEO
Exercised, kept
505,050
$0.99
$500.00K
Patrick Bilbo
10 Nov 2021
Chief Operating Officer
Exercised, kept
30,450
$1.44
$43.85K
Brian Grow
14 Apr 2020
Chief Commercial Officer
Exercised, kept
1,150
$1.70
$1.96K
Gary S. Gillheeney
5 Feb 2020
President and CEO
Exercised, kept
397,900
$1.70
$676.43K
Antonio S. Montecalvo
21 Jan 2020
VP Health Policy & Contracting
Exercised, kept
30,450
$1.70
$51.77K
Brian Grow
1 Oct 2019
Chief Commercial Officer
Exercised, kept
667
$1.70
$1.13K

What was left out

Form 4 filings counted 271
Amendments (4/A) skipped 10
Filings about a different issuer 0
Unreadable filings 0
Joint filings 56
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 21
Sales at will 62
Transactions with no price 3
Shares from compensation/vesting 287,940,282
Sales filed before the plan box existed 42
History held since 29 Nov 2016